[Monitoring the effects of oxyphilline Spofa in the umbilical-placental circulation].
Vasodilatation treatment is an inevitable part of comprehensive therapy of intrauterine growth retardation of the foetus. The authors present the results of investigations of the effect of Oxyphylline on the umbilical and placental circulation of pregnant women with confirmed disorders of the flow parameters. Oxyphylline Spofa, 3 x 100 mg orally, is the drug of choice in treatment of foetal hypotrophy with a marked effect on the umbilical and placental circulation.
Kovác
R
R
Výskumný ústav lekárskej bioniky, Oddelenie pre výskum zdravia zeny, Bratislava, CSc.
Gáboriková
V
V
Malickayová
N
N
Stencl
J
J
D005260:Female; D005317:Fetal Growth Retardation / Q000188:drug therapy*; D006801:Humans; D010920:Placenta / Q000098:blood supply*; D011247:Pregnancy; D012039:Regional Blood Flow / Q000187:drug effects; D013806:Theophylline / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014469:Umbilical Arteries / Q000503:physiopathology*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use
D014665:Vasodilator Agents; D013806:Theophylline; C008749:etofylline
Sledovanie úcinku oxyphyllinu Spofa na umbiliko-placentárnu cirkuláciu.